How to supplement hypo-androgenic women correctly

Similar documents
Androgen supplementation in women with low functional ovarian reserve

Evidence-based treatment of POR and POF. Ovarian Club X and CoGEN in Asia December 16-17, 2017 Hong Kong

Ontogeny of the new hypo-androgenic PCOS phenotype

When is it the right time to refer a patient into egg donation? It should always be the patient s choice

Debate: Natural vs. Stimulated Cycles Stimulated Cycles

Accuracy of assessing embryo ploidy of human embryos with PGS in association with IVF

Timing of Ovulation Induction Matters in Women with Low Functional Ovarian Reserve

A journey into the future of IVF

Nothing more controversial than PGS

The intra-follicular molecular biology mandating advancement of egg retrieval in some women

Evaluation of Dehydroepiandrosterone Supplementation on Diminished Ovarian Reserve: A Randomized, Double-Blinded, Placebo-Controlled Study

A pilot trial of large versus small diameter needles for oocyte retrieval

With low ovarian reserve, Highly Individualized Egg Retrieval (HIER) improves IVF results by avoiding premature luteinization

AMH CUT-OFF VALUES FOR PREDICTING OVARIAN RESPONSE IN IVF. Nguyễn Xuân Hợi, MD, PhD Hoàng Văn Hùng MsC, MD

The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age

Effect of race and ethnicity on utilization and outcomes of assisted reproductive technology in the USA

Huanhuan Zhang 1,2, Yaping Chu 1, Ping Zhou 1, Xiaojin He 1, Qianhua Xu 1, Zhiguo Zhang 1, Yunxia Cao 1 and Zhaolian Wei 1*

Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation

How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life?

A Tale of Three Hormones: hcg, Progesterone and AMH

Puberty and Fertility. Normal Female Puberty PUBERTY! What about girls with Galactosemia? E Puberty and Fertility Badik Spencer 1

Dr. Ernesto Bosch Instituto Valenciano de Infertilidad Valencia, Spain. Declared no potential conflict of interest

Huan H Zhang 1, Ping Y Xu 1, Juan Wu 1, Wei W Zou 2, Xia M Xu 2, Xia Y Cao 1 and Lian Z Wei 1*

lbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour

Infertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF

Prognosticating ovarian reserve by the new ovarian response prediction index

Vitaly A. Kushnir MD, FACOG

A Tale of Three Hormones: hcg, Progesterone and AMH

Age specific serum anti-müllerian hormone levels in 1,298 Korean women with regular menstruation

Gynecology & Reproductive Health

Association of ovarian reserve with age, BMI and serum FSH level in subfertile women

Live birth chances in women with extremely low-serum anti-mullerian hormone levels

The emergence of Personalized Medicine protocols for IVF.

The Significance of Low Anti-Müllerian Hormone Levels in Young Women Undergoing in Vitro Fertilization

Best practices of ASRM and ESHRE

Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

JMSCR Vol 06 Issue 09 Page September 2018

Prospectively assessing risk for premature ovarian senescence in young females: a new paradigm

Trends in Egg Donation. Vitaly A. Kushnir MD Center for Human Reproduction

Individualized treatment based on ovarian reserve markers

Clinical Study Comparison of IVF Outcomes between Minimal Stimulation and High-Dose Stimulation for Patients with Poor Ovarian Reserve

What is the POSEIDON concept?

ENDOCRINE CHARACTERISTICS OF ART CYCLES

Evaluation of ovarian response prediction according to age and serum AMH levels in IVF cycles: a retrospective analysis

Impact of Ovarian Endometrioma Per Se and Surgery on Ovarian Reserve and Pregnancy Rate in in Vitro Fertilization Cycles

Vitaly A. Kushnir MD, FACOG

CHR VOICE the. Inflammation and the Immune System. Welcome to 2018! The Center for Human Reproduction. monthly CHR UPDATE.

CHR VOICE the. GrandRounds. CHR s Fall Travel Plans. The Center for Human Reproduction LOCAL NEWS. Also in this issue: monthly CHR UPDATE OCTOBER 2014

Progesterone and clinical outcomes

INFERTILITY: DIAGNOSIS, WORKUP AND MANAGEMENT FOR THE COMMUNITY PHYSICIAN

COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL

Anti-Mullerian hormone (AMH) as predictor of ovarian reserve

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)

LH activity administration during the

L6: DuoStim: the alternative of oocytes/embryos accumulation programs Carlo Alviggi

Minimising IVF related mortality and morbidity. Scott Nelson Muirhead Professor in Obstetrics & Gynaecology

Sample size a Main finding b Main limitations

Antral follicle count as a predictor of ovarian response

Brief Report. What s Known. Keywords Melatonin Ovarian reserve Assisted reproductive techniques Embryo Oocytes. What s New.

CENTER FOR HUMAN REPRODUCTION - CHR 21 East 69 th Street, New York, N.Y., Telephone: ; Fax:

NGUYEN QUOC ANH. M.D., M.Sc. Tu Du Hospital Vietnam

A multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of

Manish Banker. Declared receipt of grants; member of a company advisory board, board of director or similar group

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

CHR VOICE. Practice Committee of the ASRM Publishes Updated Committee Opinion on PGS/PGT-A. The Center for Human Reproduction. the monthly CHR UPDATE

Advanced age, poor responders and the role of LH supplementation. C. Alviggi University Federico II, Naples, Italy

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins

Biomarkers for Prediction of Pregnancy Outcome in Fertility Patients. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology

Infertility: A Generalist s Perspective

Effects of HCG and LH on ovarian stimulation. Are they bioequivalent?

CHR VOICE the. Upcoming changes at CHR for the new academic year 2017/2018. The Center for Human Reproduction. monthly CHR UPDATE.

Individualized Controlled Ovarian Stimulation: Biomarker-Guided Treatment Personalization

Treatment of Poor Responders

Sesh Kamal Sunkara Aberdeen Fertility Centre Aberdeen Maternity Hospital University of Aberdeen Aberdeen, UK

Personalizing ovarian stimulation for IVF

INFERTILITY & SOCIAL EGG FREEZING Caitlin Dunne, MD, FRCSC Clinical Assistant Professor, UBC Disclosures 06/21/18.

Ongoing Pregnancy Rates in Women with Low and Extremely Low AMH Levels. A Multivariate Analysis of 769 Cycles

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

Hormone Balance - Female Report SAMPLE. result graph based on Luteal Phase. result graph based on Luteal Phase

1 (gonadotropin, Gn) -,, : - (IVF-ET); (COH); ; : R711.6 : A : X(2014)

Hold On To Your Dreams

CRB-AAB MAY 18, David F. Albertini,Ph.D. Director of Laboratories, Senior Scientist Center For Human Reproduction

Clinical Study Discrepancies between Antimullerian Hormone and Follicle Stimulating Hormone in Assisted Reproduction

International Journal of Pharma and Bio Sciences ENDOCRINE MARKERS AND DECLINE IN REPRODUCTIVE POTENTIAL OF WOMEN ABSTRACT

original article INTRODUCTION Since the introduction of anti-müllerian hormone ABSTRACT

Questions. Ultrasound markers of ovarian reserve Modena April 18-19, Your choice is.. Impact study: stop OR tests or Soft catheters??

(Predictive. value) Soheila Ansaripour Fellowship of infertility Ai Avicena Research In

Primary Ovarian Insufficiency (POI)

Intérêt de l hcg et induction de l ovulation. Christophe Blockeel, MD, PhD Centre for Reproductive Medicine, Brussels, Belgium

The Adolescent: A Patient at Risk: Ovarian Failure in Adolescent Cancer Survivors

S. AMH in PCOS Research Insights beyond a Diagnostic Marker

Correlation between androgen levels in follicular fluid and granulose cell FSHR expression in poor responder women

Gene expression of follicle-stimulating hormone receptors in granulosa cells in poor ovarian responders

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI

Do aromatase inhibitors have a place in IVF?

Bilan Hormonal. Question posée. Ovulation? Qualité de l ovulation? Vieillissement ovarien? Fonction thyroïdienne Fonction surrénalienne

Chern et al. Reproductive Biology and Endocrinology (2018) 16:90 (Continued on next page)

Pre-implantation genetic diagnosis and pre-implantation genetic screening: two years experience at a single center

Transcription:

How to supplement hypo-androgenic women correctly Norbert Gleicher, MD Medical Director and Chief Scientist, Center For Human Reproduction, New York, NY President, Foundation For Reproductive Medicine, New York, NY Guest Investigator, Rockefeller University, New York, NY Professor (Adj), Department Of Obstetrics & Gynecology, Vienna University School Of Medicine, Vienna, Austria FRMC 2018 New York, NY November 15-18, 2018

Conflict Statement Dr. Gleicher is listed as co-inventor on a number of pending patent applications claiming diagnostic and therapeutic benefits from determination of CGG repeat numbers and ovarian FMR1 genotypes and sub-genotypes. Dr. Gleicher is co-inventor of awarded U.S. patents, claiming therapeutic benefits for supplementation of DHEA in women with diminished ovarian reserve, a topic discussed in this talk. Other patent applications in regards to DHEA and other fertility-related claims, with no relationship to this talk, are pending. Dr. Gleicher receives royalties from, and owns shares in Fertility Neutraceuticals, LLC, a distributor of a DHEA product. Dr. Gleicher is co-inventor of three pending patent applications claiming potential therapeutic benefit for anti-müllerian hormone (AMH) in infertile women. Dr. Gleicher owns shares in OvaNova Laboratories, LLC.

FSH and Androgen Receptors Reproductive Biology and Endocrinology 2011, 9:116 doi:10.1186/1477-7827-9-116

DHEA Mimics DHT Effects on Follicular Development Antral Follicle Count Percent of Follicles 20 10 0 FSH FSH + DHEA FSH + DHEA + Flutamide FSH (10ng/ml) DHEA (100nM) Flutamide (100nM) Sen et al; Personal Communication

DHEA in DOR Patients - IVF DHEA 3βHSD Androstenedione CYP19 Estrone 17βHSD Androstenediol 3βHSD 17βHSD Testosterone CYP19 17βHSD Estradiol AR Follicular survival AMH expression FSH sensitivity DHEA AFC Sen et al; Personal Communication # of oocytes retrieved during IVF

The DHEA Story

Egg and Embryo Yields Count 20 18 16 14 12 10 8 6 4 2 0 D H E A Eggs Embryos 1 2 3 4 5 6 7 8 9 Treatment Cycle Gleicher and Barad, Fertil Steril 2005;84(3):756.

Previously Reported Reproductive Benefits of DHEA Improves egg/embryo numbers Improves egg/embryo quality Improves spontaneous pregnancy rates Improves IVF pregnancy rates Improves time to conception Improves cumulative pregnancy rates Casson et al. Hum Reprod 2000 Barad and Gleicher, Hum Reprod 2006 Barad and Gleicher, Fertil Steril 2005 Barad et al, J Assist Reprod Genet 2007

AMH response to DHEA Reprod Biomed Online 2010: 360-365.

Comparison of Miscarriage Rates between DHEA Supplemented Infertility Patients and 2004 National US IVF Outcome Data. 0.6 0.5 0.4 0.3 0.2 National DHEA 0.1 0 <35 35-37 38-40 41-42 >42 Gleicher et al, Reprod Biol Endocrinol 2009;7:108

Gleicher et al., Reprod Biol Endocrinol 2010;8:140. Comparison of Absolute and Percentages of Aneuploidy in DHEA and Control Patients

Androgens, Cortisol and Ratios DOR is an androgen deficiency state Box and whisker plots of serum androgen levels, serum cortisol levels and the ratio of total testosterone concentration over serum cortisol levels for controls, POA/OPOI, and physicologic DOR. The mean is depicted with a dashed line, the median with a solid line, and the normal range for serum androgens with a grey background. (a) Comparison of serum androgen levels: an asterisk denotes significant differences in mean between groups. (b) Shows distribution of serum cortisol levels. (c) Shows the ratio of TT over cortisol levels. Gleicher et al, Hum. Reprod. 2013: 28 (4):1084-1091.

Testosterone Response

Follicle Development from Primordial and Preovulatory Status NEW OLD Broekmans FJ et al, Endocrine Reviews 2009

Summary Preferred supplementation: DHEA Alternative: Testosterone At least 6 weeks before IVF start Preferably controlled by T and SHBG loads Co-supplementation: CoQ10 Per need: HGH, etc.

Side effects DHEA: less than Testosterone Improved libido Oily skin/acne Hair loss CoQ10: None HGH Ankle swelling Joint pains Carpal tunnel/edema

CHR Staff (* Visiting Scientists) David F Albertini, PhD* David H Barad, MS, MD Ali Brivanlou, PhD, MD* Sarah Darmon, PhD, MS* Dieter Egli, PhD* Norbert Gleicher, MD Jianjun Hu, MD, MS Vitaly A Kushnir, MD Emanuela Lazzaroni-Tealdi, MS Aya Shohat-Tal, PhD* Andrea Vidali, MD* Andrea Weghofer, PhD, MS, MBA, MD* Yao Yu, PhD* Affiliates Rockefeller University: Ali Brivanlou, PhD, MD Salk Institute for Biological Studies: Pradeep Reddy, PhD